Genetic polymorphism of the hepatic cytochrome P450 2C19 in North Indian subjects*
- 3 April 1998
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 63 (4) , 422-427
- https://doi.org/10.1016/s0009-9236(98)90037-6
Abstract
One hundred unrelated healthy North Indian subjects were phenotyped with respect to their ability to metabolize omeprazole to 5-hydroxyomeprazole. Each volunteer was requested to ingest 20 mg (57.9 mumol) omeprazole. Urine was collected for a period of 8 hours and the amount of 5-hydroxyomeprazole excreted was estimated by HPLC. Histogram, probit, and normal test variable plots showed the antimode value for the log hydroxylation index of omeprazole to be 1.7. Of 100 North Indian subjects, 11 demonstrated log hydroxylation index values more than 1.7. Thus it is inferred that the frequency of occurrence of poor metabolizers of omeprazole in North Indian subjects is 11% (95% confidence interval, 5% to 17%). From the Hardy-Weinberg Law it was computed that the frequency of occurrence of the mutant allele of hepatic CYP2C19 in the North Indian subjects was 0.33.Keywords
This publication has 18 references indexed in Scilit:
- Genetic analysis of the S-mephenytoin polymorphism in a chinese population*Clinical Pharmacology & Therapeutics, 1995
- Debrisoquine and mephenytoin oxidation in Sinhalese: a population study.British Journal of Clinical Pharmacology, 1994
- Simultaneous determination of omeprazole and its metabolites in plasma and urine by reversed-phase high-performance liquid chromatography with an alkaline-resistant polymer-coated C18 columnJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- A new, sensitive graphical method for detecting deviations from the normal distribution of drug responses: the NTV plot.Published by Wiley ,1991
- The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspectsPharmacology & Therapeutics, 1990
- Frequency of impaired mephenytoin 4′-hydroxylation in an Indian population [letter]Published by Wiley ,1990
- Slow Omeprazole Metabolizers Are Also Poor S-Mephenytoin HydroxylatorsTherapeutic Drug Monitoring, 1990
- Genetic polymorphism of S-mephenytoin hydroxylationPharmacology & Therapeutics, 1989
- Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotypeClinical Pharmacology & Therapeutics, 1989